The life sciences industry in India is on the cusp of change. This has been possible due to the recent scientific and technological advancements coupled with an ageing population, expansion in the emerging markets and an exponential increase in the mainstream adoption of digital technologies. The industry now has a renewed platform to revive its fortunes. This transition has opened up new opportunities for a new breed of start-ups that are preparing for the future by embracing next-gen technologies, systems and best practices. Gujarat-based Tanishi Lifescience, a reputed name as Manufacturer, Supplier, Exporter of Pharmaceutical Ingredients, API Intermediates and its intermediate is one such new-age start-up that is defining and measuring health outcomes and is leveraging opportunities and navigating challenges to carve a niche in the industry.

The journey of Tanishi Lifescience, a culmination of a dream of a young visionary industrialist, began in 2017 with a concept to produce the best quality medicines at the most affordable prices with innovations and make strong presence not only in domestic market but as well as in global scenarios. As part of business conglomerate which has varied business interest, cutting across continents, Tanishi Lifescience entered into Indian

Pharmaceutical market to play a pivotal role in alleviating the human sufferings through its quality, innovative and affordable medicines. Since then, the company has been highly acknowledged in the industry for its features like effectiveness, premium quality components and free from adulteration. "Our products like Pharmaceutical Ingredients for Ortho, Gynaec, General, Nutraceutical, amongst others have helped us to serve a long list of clients all over the globe," says Marmik Patel, CEO.

A New Phase of Growth
The dexterous team at Tanishi Lifescience believes in adding to quality of life by dis-covering, developing, and marketing pharma products that meet the needs of their customers. Also, the company plays a pivotal role in alleviating the human sufferings through its quality, innovative and affordable medicines. "We at Tanishi always believe to design such brands to ease the pain and discomforts of patients to meet prescription demand of prescribers' so as to improve confidence among medical fraternity as well as of patients," he says. The company aims to strengthen its presence further in therapeutic segments like Anti-bacterial, Anti-inflammatory, Analgesics, Nutritional, Cardiology and Diabetology by introducing new, improved molecules and dosage forms. "To strengthen our port-folio further we are in touch with our manufacturers to bring newly advance molecules with dosage advantages & least interactions. Indian pharmaceutical industries always welcome newer molecules & existing drugs combination to meet the requirements of prescribers. We are also working towards introducing products in new therapeutic segments to broaden our base," he informs.

The Journey
Since inception, Tanishi Lifescience has strived to create a strong foothold in the industry. It is thoroughly and incessantly trying to improve its presence through its innovative products' portfolio to serve its customers. "Since the beginning of our inception, we planned our strategies in such a way so that align with our objectives, earn profits, cater quality to the clients and focus on organisational growth & expansion. Our endeavour is to improve quality of life through molecular and biological benefits," he adds.

In the coming years, the company aims to improve sales of each and every individual brand as well increase coverage by inducting fresh field force and opening new headquarters across India. "Our long-term goal is to step ahead from a small entrepreneurial life science pharma company to global corporation. We aim to achieve increased performance by improving efficacy and effectiveness of company key business operation," he concludes.